Source: Pharmacogenomics. Unidade: FMRP
Subjects: ÓXIDO NÍTRICO, POLIMORFISMO, FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUIZON, Marcelo Rizzatti e PEREIRA, Daniela A. e TANUS-SANTOS, José Eduardo. Pharmacogenetic relevance of endothelial nitric oxide synthase polymorphisms and gene interactions. Pharmacogenomics, v. 19, n. 18, p. 1423-1435, 2018Tradução . . Disponível em: https://doi.org/10.2217/pgs-2018-0098. Acesso em: 29 jan. 2026.APA
Luizon, M. R., Pereira, D. A., & Tanus-Santos, J. E. (2018). Pharmacogenetic relevance of endothelial nitric oxide synthase polymorphisms and gene interactions. Pharmacogenomics, 19( 18), 1423-1435. doi:10.2217/pgs-2018-0098NLM
Luizon MR, Pereira DA, Tanus-Santos JE. Pharmacogenetic relevance of endothelial nitric oxide synthase polymorphisms and gene interactions [Internet]. Pharmacogenomics. 2018 ; 19( 18): 1423-1435.[citado 2026 jan. 29 ] Available from: https://doi.org/10.2217/pgs-2018-0098Vancouver
Luizon MR, Pereira DA, Tanus-Santos JE. Pharmacogenetic relevance of endothelial nitric oxide synthase polymorphisms and gene interactions [Internet]. Pharmacogenomics. 2018 ; 19( 18): 1423-1435.[citado 2026 jan. 29 ] Available from: https://doi.org/10.2217/pgs-2018-0098
